These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32780212)
1. Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study. Houvast RD; Baart VM; Bhairosingh SS; Cordfunke RA; Chua JX; Vankemmelbeke M; Parsons T; Kuppen PJK; Durrant LG; Vahrmeijer AL; Sier CFM Mol Imaging Biol; 2020 Dec; 22(6):1511-1522. PubMed ID: 32780212 [TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors. Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046 [TBL] [Abstract][Full Text] [Related]
3. In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis. Yang Y; Zhang Y; Hong H; Liu G; Leigh BR; Cai W Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2066-76. PubMed ID: 21814852 [TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer. Houvast RD; Badr N; March T; de Muynck LDAN; Sier VQ; Schomann T; Bhairosingh S; Baart VM; Peeters JAHM; van Westen GJP; Plückthun A; Burggraaf J; Kuppen PJK; Vahrmeijer AL; Sier CFM Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2179-2192. PubMed ID: 37642704 [TBL] [Abstract][Full Text] [Related]
5. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models. Hollandsworth HM; Lwin TM; Amirfakhri S; Filemoni F; Batra SK; Hoffman RM; Dhawan P; Bouvet M J Surg Res; 2019 Oct; 242():145-150. PubMed ID: 31077946 [TBL] [Abstract][Full Text] [Related]
6. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody. Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882 [TBL] [Abstract][Full Text] [Related]
7. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody. Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560 [TBL] [Abstract][Full Text] [Related]
8. ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma. Li M; Wei W; Barnhart TE; Jiang D; Cao T; Fan K; Engle JW; Liu J; Chen W; Cai W Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2737-2748. PubMed ID: 33537836 [TBL] [Abstract][Full Text] [Related]
9. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW. Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144 [TBL] [Abstract][Full Text] [Related]
10. EpCAM as multi-tumour target for near-infrared fluorescence guided surgery. van Driel PB; Boonstra MC; Prevoo HA; van de Giessen M; Snoeks TJ; Tummers QR; Keereweer S; Cordfunke RA; Fish A; van Eendenburg JD; Lelieveldt BP; Dijkstra J; van de Velde CJ; Kuppen PJ; Vahrmeijer AL; Löwik CW; Sier CF BMC Cancer; 2016 Nov; 16(1):884. PubMed ID: 27842504 [TBL] [Abstract][Full Text] [Related]
11. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors. Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899 [TBL] [Abstract][Full Text] [Related]
12. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence. Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463 [TBL] [Abstract][Full Text] [Related]
15. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma. Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891 [TBL] [Abstract][Full Text] [Related]
17. Humanized Anti-Tumor-Associated Glycoprotein-72 for Submillimeter Near-Infrared Detection of Colon Cancer in Metastatic Mouse Models. Hollandsworth HM; Amirfakhri S; Filemoni F; Hoffman RM; Molnar J; Yazaki PJ; Bouvet M J Surg Res; 2020 Aug; 252():16-21. PubMed ID: 32217350 [TBL] [Abstract][Full Text] [Related]
18. Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study. Mulder BGS; Koller M; Duiker EW; Sarasqueta AF; Burggraaf J; Meijer VE; Vahrmeijer AL; Hoogwater FJH; Bonsing BA; van Dam GM; Mieog JSD; Pranger BK J Nucl Med; 2023 Jan; 64(1):82-89. PubMed ID: 35680414 [TBL] [Abstract][Full Text] [Related]